{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:04:14Z","timestamp":1761782654839,"version":"build-2065373602"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["UL1 TR002377"],"award-info":[{"award-number":["UL1 TR002377"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This medical center migrated from alcohol to sotradecol foam sclerotherapy (SFS) because of perceived improved efficacy in managing symptomatic kidney and liver cysts. We report technical aspects, change in short- and long-term cyst volumes, patient-reported outcomes, safety and applications of the technique.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective observational study, cases from January 2017 to December 2021 had TKCV\/TLCV (per Targeted Kidney or Liver or Cyst analysis) segmented using a deep-learning algorithm and cyst segmentation software (pre-, post-procedure and longitudinally). TKCV\/TLCV % change were evaluated using the one-sample Wilcoxon signed rank test. For analyses involving changes in cyst volumes, the median % change in cyst volume per patient was assessed. Longitudinal changes in cyst volumes were assessed using linear mixed models. Changes in quality of life (QOL) [Linear Analog Self-Assessment (LASA), Polycystic Liver Disease Quality of life Questionnaire (PLD-Q) and 12-item short-form (SF12)] were also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 102 SFS sessions (38 kidney, 58 liver, 6 combined liver\/kidney cysts) performed on 77 unique individuals included for analysis. Median [interquartile range (IQR)] % reductions in TKCV were \u201392.0% (IQR \u201398.2%, \u201382.7%, P\u00a0&amp;lt;\u00a0.001) and for TLCV were \u201383.1% (IQR \u201393.5%, \u201352.9%, P\u00a0&amp;lt;\u00a0.001). Among patients with multiple kidney procedures (n\u00a0=\u00a07), median % reduction in TKCV was \u201394.3% (IQR \u201396.6%, \u201392.4%, P\u00a0=\u00a0.023). For patients with multiple liver procedures (n\u00a0=\u00a011), median % reduction in TLCV was \u201363.3% (IQR \u201385.2%, \u201328.3%, P\u00a0=\u00a0.004). Results were similar among the four patients undergoing multi-stage procedures (n\u00a0=\u00a01 kidney, n\u00a0=\u00a03 liver). When measured longitudinally, both liver and kidney cyst volumes declined to levels near 0\u00a0mL by 1\u00a0year follow-up and remained stable several years later. LASA physical domain and PLD-Q QOL scores improved post-SFS procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SFS led to substantial long-term reductions in TKCV\/TLCV and improved QOL. SFS can augment cyst volume reduction in addition to tolvaptan (kidney cysts) and octreotide (liver cysts). In some individuals with large symptomatic cysts, multiple SFS procedures were safe and effective in reducing TLCV\/TKCV and improving symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfaf111","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T07:52:26Z","timestamp":1750924346000},"page":"2169-2181","source":"Crossref","is-referenced-by-count":0,"title":["Foam sclerotherapy for symptomatic cysts in ADPKD, ADPLD and solitary cysts"],"prefix":"10.1093","volume":"40","author":[{"given":"Newton","family":"Neidert","sequence":"first","affiliation":[{"name":"Mayo Clinic Radiology Department, , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Kseibi","sequence":"additional","affiliation":[{"name":"Mayo Clinic Division of Nephrology & Hypertension, Department of Internal Medicine, , Rochester, MN ,","place":["USA"]},{"name":"College of Medicine, Alfaisal University , Riyadh,","place":["Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William P","family":"Martin","sequence":"additional","affiliation":[{"name":"Mayo Clinic Division of Nephrology & Hypertension, Department of Internal Medicine, , Rochester, MN ,","place":["USA"]},{"name":"Washington University in St Louis Division of Nephrology, Department of Medicine, , St Louis, MO ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seif","family":"Bugazia","sequence":"additional","affiliation":[{"name":"Mayo Clinic Division of Nephrology & Hypertension, Department of Internal Medicine, , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Bendel","sequence":"additional","affiliation":[{"name":"Mayo Clinic Radiology Department, , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassie","family":"Howe","sequence":"additional","affiliation":[{"name":"Mayo Clinic Division of Nephrology & Hypertension, Department of Internal Medicine, , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Helland","sequence":"additional","affiliation":[{"name":"Mayo Clinic Division of Nephrology & Hypertension, Department of Internal Medicine, , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Gregory","sequence":"additional","affiliation":[{"name":"Radiology Research, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Liestikow","sequence":"additional","affiliation":[{"name":"Mayo Clinic Division of Nephrology & Hypertension, Department of Internal Medicine, , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Kline","sequence":"additional","affiliation":[{"name":"Mayo Clinic Radiology Department, , Rochester, MN ,","place":["USA"]},{"name":"Radiology Research, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Vaughan","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Health Sciences Research, Biostatistics, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente E","family":"Torres","sequence":"additional","affiliation":[{"name":"Mayo Clinic Division of Nephrology & Hypertension, Department of Internal Medicine, , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3031-8522","authenticated-orcid":false,"given":"Marie C","family":"Hogan","sequence":"additional","affiliation":[{"name":"Mayo Clinic Division of Nephrology & Hypertension, Department of Internal Medicine, , Rochester, MN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"2025102920023672800_bib1","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1681\/ASN.V1181505","article-title":"Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease","volume":"11","author":"King","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"2025102920023672800_bib2","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"2025102920023672800_bib3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cgh.2014.07.051","article-title":"Liver involvement in early autosomal-dominant polycystic kidney disease","volume":"13","author":"Hogan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025102920023672800_bib4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1053\/jhep.2003.50006","article-title":"Clinical profile of autosomal dominant polycystic liver disease","volume":"37","author":"Qian","year":"2003","journal-title":"Hepatology"},{"key":"2025102920023672800_bib5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ekir.2023.02.1073","article-title":"OVERTURE: a worldwide, prospective, observational study of disease characteristics in patients with ADPKD","volume":"8","author":"Perrone","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2025102920023672800_bib6","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1093\/ckj\/sfac144","article-title":"Flank pain has a significant adverse impact on quality of life in ADPKD: the CYSTic-QoL study","volume":"15","author":"Winterbottom","year":"2022","journal-title":"Clin Kidney J"},{"key":"2025102920023672800_bib7","doi-asserted-by":"publisher","first-page":"e0144526","DOI":"10.1371\/journal.pone.0144526","article-title":"Clinical correlates of mass effect in autosomal dominant polycystic kidney disease","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"2025102920023672800_bib8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/j.1523-1755.2004.00921.x","article-title":"Pain patterns in patients with polycystic kidney disease","volume":"66","author":"Bajwa","year":"2004","journal-title":"Kidney Int"},{"key":"2025102920023672800_bib9","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/ndt\/gfv299","article-title":"Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease","volume":"31","author":"Simms","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2025102920023672800_bib10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1053\/j.ajkd.2013.08.017","article-title":"Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study","volume":"63","author":"Miskulin","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2025102920023672800_bib11","doi-asserted-by":"publisher","first-page":"100821","DOI":"10.1016\/j.xkme.2024.100821","article-title":"The importance of recognizing pain in patients with autosomal dominant polycystic kidney disease","volume":"6","author":"Geertsema","year":"2024","journal-title":"Kidney Med"},{"key":"2025102920023672800_bib12","doi-asserted-by":"publisher","first-page":"100813","DOI":"10.1016\/j.xkme.2024.100813","article-title":"Pain and health-related quality of life in autosomal dominant polycystic kidney disease: results from a national patient-powered registry","volume":"6","author":"Hoover","year":"2024","journal-title":"Kidney Med"},{"key":"2025102920023672800_bib13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2215\/CJN.08660621","article-title":"Volume progression and imaging classification of polycystic liver in early autosomal dominant polycystic kidney disease","volume":"17","author":"Bae","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102920023672800_bib14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2215\/CJN.10360818","article-title":"Growth pattern of kidney cyst number and volume in autosomal dominant polycystic kidney disease","volume":"14","author":"Bae","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025102920023672800_bib15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/SLA.0b013e3181ad83dc","article-title":"Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation","volume":"250","author":"Schnelldorfer","year":"2009","journal-title":"Ann Surg"},{"key":"2025102920023672800_bib16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000525575","article-title":"The need for routine native nephrectomy in the workup for kidney transplantation in autosomal dominant polycystic kidney disease patients","volume":"107","author":"Casteleijn","year":"2023","journal-title":"Urol Int"},{"key":"2025102920023672800_bib17","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3390\/jcm8101622","article-title":"Native nephrectomy before and after renal transplantation in patients with autosomal dominant polycystic kidney disease (ADPKD)","volume":"8","author":"Maxeiner","year":"2019","journal-title":"J Clin Med"},{"key":"2025102920023672800_bib18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2025102920023672800_bib19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00464-018-6490-8","article-title":"Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: a systematic review and meta-analysis","volume":"33","author":"Bernts","year":"2019","journal-title":"Surg Endosc"},{"key":"2025102920023672800_bib20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2214\/AJR.16.16130","article-title":"Efficacy and safety of aspiration sclerotherapy of simple hepatic cysts: a systematic review","volume":"208","author":"Wijnands","year":"2017","journal-title":"Am J Roentgenol"},{"key":"2025102920023672800_bib21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12882-017-0578-6","article-title":"The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression","volume":"18","author":"Neijenhuis","year":"2017","journal-title":"BMC Nephrol"},{"key":"2025102920023672800_bib22","first-page":"175","article-title":"Ultrasound-guided percutaneous drainage and sclerotherapy in a patient with isolated autosomal dominant polycystic liver disease","volume":"107","author":"Barbado-Cano","year":"2015","journal-title":"Rev Esp Enferm Dig"},{"key":"2025102920023672800_bib23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/00000658-198908000-00012","article-title":"Percutaneous aspiration and alcohol sclerotherapy for symptomatic hepatic cysts. An alternative to surgical intervention","volume":"210","author":"Kairaluoma","year":"1989","journal-title":"Ann Surg"},{"key":"2025102920023672800_bib24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.urology.2006.03.080","article-title":"Selective ablation of symptomatic dominant renal cysts using 99% ethanol in adult polycystic kidney disease","volume":"68","author":"Singh","year":"2006","journal-title":"Urology"},{"key":"2025102920023672800_bib25","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/hep.24036","article-title":"Medical and surgical treatment options for polycystic liver disease","volume":"52","author":"Drenth","year":"2010","journal-title":"Hepatology"},{"key":"2025102920023672800_bib26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2024.07.009","article-title":"KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD)","volume":"107","author":"Kidney Disease: Improving Global Outcomes (KDIGO) ADPKD Work Group","year":"2025","journal-title":"Kidney Int"},{"key":"2025102920023672800_bib27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.xkme.2019.07.015","article-title":"Foam sclerotherapy for cyst volume reduction in autosomal dominant polycystic kidney disease: a prospective cohort study","volume":"1","author":"Iliuta","year":"2019","journal-title":"Kidney Med"},{"key":"2025102920023672800_bib28","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s00270-013-0761-5","article-title":"Foam sclerotherapy for a symptomatic hepatic cyst: a preliminary report","volume":"37","author":"Itou","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2025102920023672800_bib29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jvir.2022.02.017","article-title":"Safety of high-dose 3% sodium tetradecyl sulfate for sclerotherapy of renal cysts in patients with autosomal dominant polycystic kidney disease","volume":"33","author":"Patel","year":"2022","journal-title":"J Vasc Interv Radiol"},{"key":"2025102920023672800_bib30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/hepr.13202","article-title":"Ultrasound-guided microfoam sclerotherapy with polidocanol for symptomatic giant hepatic cyst: initial experience","volume":"48","author":"Eso","year":"2018","journal-title":"Hepatol Res"},{"key":"2025102920023672800_bib31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/hepr.13769","article-title":"Ultrasound-guided polidocanol foam sclerotherapy for symptomatic giant hepatic cyst: a single-center experience","volume":"52","author":"Eso","year":"2022","journal-title":"Hepatol Res"},{"key":"2025102920023672800_bib32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/hepr.12763","article-title":"Prediction of hepatic cyst recurrence after minocycline hydrochloride aspiration sclerotherapy using cyst computed tomography values","volume":"47","author":"Iijima","year":"2017","journal-title":"Hepatol Res"},{"key":"2025102920023672800_bib33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00042737-199602000-00015","article-title":"Treatment of a symptomatic hepatic cyst by tetracycline hydrochloride instillation sclerosis","volume":"8","author":"Davies","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025102920023672800_bib34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11255-007-9316-5","article-title":"Percutaneous injection sclerotherapy with tetracycline hydrochloride in simple renal cysts","volume":"40","author":"Kilinc","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"2025102920023672800_bib35","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1259\/bjr\/41664864","article-title":"Sclerotherapy of renal cysts using acetic acid: a comparison with ethanol sclerotherapy","volume":"81","author":"Cho","year":"2008","journal-title":"Br J Radiol"},{"key":"2025102920023672800_bib36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s002700010039","article-title":"Acetic acid as a sclerosing agent for renal cysts: comparison with ethanol in follow-up results","volume":"23","author":"Seo","year":"2000","journal-title":"Cardiovasc Intervent Radiol"},{"article-title":"Application","year":"1972","author":"Research CfDEa","key":"2025102920023672800_bib37"},{"key":"2025102920023672800_bib38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s10278-017-9978-1","article-title":"Performance of an artificial multi-observer deep neural network for fully automated segmentation of polycystic kidneys","volume":"30","author":"Kline","year":"2017","journal-title":"J Digit Imaging"},{"key":"2025102920023672800_bib39","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00261-020-02748-4","article-title":"Automatic semantic segmentation of kidney cysts in MR images of patients affected by autosomal-dominant polycystic kidney disease","volume":"46","author":"Kline","year":"2021","journal-title":"Abdom Radiol"},{"key":"2025102920023672800_bib40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fninf.2014.00013","article-title":"ITK: enabling reproducible research and open science","volume":"8","author":"McCormick","year":"2014","journal-title":"Front Neuroinform"},{"key":"2025102920023672800_bib41","doi-asserted-by":"publisher","first-page":"334\u201342","DOI":"10.1016\/j.kint.2023.01.010","article-title":"Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation","volume":"104","author":"Gregory","year":"2023","journal-title":"Kidney Int"},{"key":"2025102920023672800_bib42","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s10278-021-00452-3","article-title":"Semantic instance segmentation of kidney cysts in MR images: a fully automated 3D approach developed through active learning","volume":"34","author":"Gregory","year":"2021","journal-title":"J Digit Imaging"},{"key":"2025102920023672800_bib43","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000000924","article-title":"Deep-learning-based instance-level segmentation of kidney and liver cysts in CT images of patients affected by polycystic kidney Disease","author":"Gregory","year":"2025","journal-title":"Kidney 360"},{"key":"2025102920023672800_bib44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12955-014-0187-z","article-title":"Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales","volume":"12","author":"Singh","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"2025102920023672800_bib45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/hep.28545","article-title":"Development and validation of a disease-specific questionnaire to assess patient-reported symptoms in polycystic liver disease","volume":"64","author":"Neijenhuis","year":"2016","journal-title":"Hepatology"},{"key":"2025102920023672800_bib46","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"2025102920023672800_bib47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"2025102920023672800_bib48","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1089\/end.2006.0462","article-title":"Comparison of ethanol and sodium tetradecyl sulfate in the sclerotherapy of renal cyst","volume":"21","author":"Demir","year":"2007","journal-title":"J Endourol"},{"key":"2025102920023672800_bib49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0090-4295(00)00889-X","article-title":"Treatment of renal cysts with single-session percutaneous drainage and ethanol sclerotherapy: long-term outcome","volume":"57","author":"Paananen","year":"2001","journal-title":"Urology"},{"key":"2025102920023672800_bib50","doi-asserted-by":"publisher","first-page":"e32114","DOI":"10.1097\/MD.0000000000032114","article-title":"Efficacy of single-session 99.5% ethanol sclerotherapy for incidentally found simple renal cysts","volume":"101","author":"Kim","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"2025102920023672800_bib51","doi-asserted-by":"publisher","first-page":"531","DOI":"10.7863\/jum.1998.17.8.531","article-title":"Complications of percutaneous ethanol ablation","volume":"17","author":"Gelczer","year":"1998","journal-title":"J Ultrasound Med"},{"key":"2025102920023672800_bib52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3348\/kjr.2003.4.4.239","article-title":"Ablation of symptomatic cysts using absolute ethanol in 11 patients with autosomal-dominant polycystic kidney disease","volume":"4","author":"Lee","year":"2003","journal-title":"Korean J Radiol"},{"key":"2025102920023672800_bib53","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mayocp.2022.12.019","article-title":"Clinical implementation of an artificial intelligence algorithm for magnetic resonance-derived measurement of total kidney volume","volume":"98","author":"Potretzke","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"2025102920023672800_bib54","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.34067\/KID.0003192022","article-title":"Automated kidney and liver segmentation in MR images in patients with autosomal dominant polycystic kidney disease: a multicenter study","volume":"3","author":"Woznicki","year":"2022","journal-title":"Kidney360"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf111\/63627544\/gfaf111.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/40\/11\/2169\/65001726\/gfaf111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/40\/11\/2169\/65001726\/gfaf111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:02:43Z","timestamp":1761782563000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/40\/11\/2169\/8178516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6,30]]},"published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf111","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"type":"print","value":"0931-0509"},{"type":"electronic","value":"1460-2385"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,6,30]]}}}